Clinical trial
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
NCT00198510 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00198510 |
|---|---|
| Title | Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage |
| Official title | Phase III Safety and Efficacy Study of Vitrase (Ovine Hyaluronidase) for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vitreous Hemorrhage, Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | Vitrase |
| Enrollment | 750 |
| Start date | Nov 1, 1998 |
| Primary completion | Sep 1, 2001 |
| Completion | Mar 1, 2003 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 15, 2013 |
| Countries | Canada, Mexico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: